Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients

Clinical trial NCT04696939 · UNKNOWN

Trial details

NCT number: NCT04696939
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Small-cell Lung Cancer Neoadjuvant Therapy

Start date: 2021-01-01
Primary completion: 2022-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.